#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	242	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1064	12.1	0	.	p	.	0	K29T	NONSYN	85	87	AAG	288	290	ACG	11;12;12	A;C;G	11;12;12	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	242	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1064	12.1	0	.	p	.	0	T209S	NONSYN	625	627	ACT	828	830	TCT	7;7;7	T,A;C;T	6,1;7;7	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	150	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c4.ctg.3	111	11.4	0	.	n	.	0	G906T	SNP	906	906	G	14	14	T	6	T	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	150	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c4.ctg.3	111	11.4	0	.	n	.	0	G908A	SNP	908	908	G	16	16	A	6	A	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	150	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c4.ctg.3	111	11.4	0	.	n	.	0	A918T	SNP	918	918	A	26	26	T	6	T	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	150	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c4.ctg.3	111	11.4	0	.	n	.	0	A943G	SNP	943	943	A	51	51	G	17	G	17	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	150	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c4.ctg.3	111	11.4	0	.	n	.	0	G991T	SNP	991	991	G	99	99	T	14	T	14	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	641	932	Escherichia_coli_EF_Tu	1185	1049	99.33	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1225	35.1	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1044	1046	AGC	16;16;16	A,G;G;C	12,4;16;16	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	641	932	Escherichia_coli_EF_Tu	1185	131	96.18	Escherichia_coli_EF_Tu.l15.c30.ctg.2	375	13.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	364	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c4.ctg.1	1583	11.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1401	1403	AAA	3;3;3	A;A;A	3;3;3	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	484	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l15.c17.ctg.1	1544	16.3	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1137	1139	GAA	19;19;19	G;A;A	19;19;19	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	112	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	800	7.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	380	PmrB_1	1092	1092	99.18	PmrB_1.l15.c17.ctg.1	1400	14.5	0	.	p	.	0	H2R	NONSYN	4	6	CAT	197	199	CGT	12;12;12	C;G;T	12;12;12	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	380	PmrB_1	1092	1092	99.18	PmrB_1.l15.c17.ctg.1	1400	14.5	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1040	1042	GGC	13;12;12	G;G;C	12;11;12	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	548	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1969	15.0	0	.	p	.	0	R8S	NONSYN	22	24	AGA	161	163	AGC	7;7;7	A;G;C	7;7;7	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	548	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1969	15.0	0	.	p	.	0	I142L	NONSYN	424	426	ATA	563	565	CTA	9;10;10	C;T;A	9;10;10	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	548	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1969	15.0	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1082	1084	CAA	18;19;19	C;A;A,C	18;19;18,1	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	548	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1969	15.0	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1181	1183	GGT	21;21;22	G;G;T	21;21;22	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	548	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1969	15.0	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1751	1753	GTT	11;10;10	G;T;T	11;10;10	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	234	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1443	8.6	0	.	p	.	0	A125E	NONSYN	373	375	GCA	581	583	GAA	7;7;5	G;A;A	7;7;5	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	234	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1443	8.6	0	.	p	.	0	M185T	NONSYN	553	555	ATG	761	763	ACC	3;3;4	A;C;C	3;3;4	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	234	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1443	8.6	0	.	p	.	0	S225T	NONSYN	673	675	TCC	881	883	ACT	5;4;4	A;C;T	5;4;4	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	234	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1443	8.6	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1271	1273	ATC	3;3;3	A;T;C	3;3;3	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	298	PmrF	969	969	99.38	PmrF.l15.c17.ctg.1	1250	12.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_183.3001045.HQ529916.110_971.1647	TEM_183.3001045.HQ529916.110_971.1647	1	0	539	390	TEM_1+	861	861	99.88	TEM_1+.l15.c30.ctg.1	1228	17.0	0	.	p	.	0	L228F	NONSYN	682	684	CTT	873	875	TTT	21;21;22	T,G;T;T	17,1;21;21	.	TEM-183 is a broad-spectrum beta-lactamase.;TEM-183
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	531	762	acrD	3114	3102	99.07	acrD.l15.c4.ctg.2	3304	12.3	0	.	p	.	0	T85I	NONSYN	253	255	ACC	455	457	ATC	8;8;8	A;T;C	8;8;8	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	531	762	acrD	3114	3102	99.07	acrD.l15.c4.ctg.2	3304	12.3	0	.	p	.	0	G549S	NONSYN	1645	1647	GGC	1847	1849	AGC	17;17;17	A,G;G;C	16,1;17;17	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	531	762	acrD	3114	3102	99.07	acrD.l15.c4.ctg.2	3304	12.3	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2168	2170	AAG	11;10;10	A;A;G	11;10;10	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	320	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1439	11.7	0	.	p	.	0	A22V	NONSYN	64	66	GCC	263	265	GTC	5;5;5	G;T;C	5;5;5	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	320	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1439	11.7	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1004	1006	TGC	10;9;10	T;G;C	10;9;10	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	920	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3210	15.1	0	.	p	.	0	S46trunc	TRUNC	136	136	T	168	168	T	12	T	12	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	920	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3210	15.1	0	.	p	.	0	G148D	NONSYN	442	444	GGC	474	476	GAC	6;6;6	G;A;C	6;6;6	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	920	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3210	15.1	0	.	p	.	0	F240L	NONSYN	718	720	TTT	750	752	TTA	8;8;8	T;T;A	8;8;8	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	920	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3210	15.1	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1827	1829	AAT	16;17;17	A;A;T	16;17;17	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	920	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3210	15.1	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1941	1943	AGT	12;12;13	A;G;T	12;12;13	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	920	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3210	15.1	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2340	2342	GTG	14;13;13	G;T;G	14;13;13	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	920	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3210	15.1	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2895	2897	AAG	19;18;21	A;A;G	19;18;21	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	218	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1009	11.6	1	SNP	p	R45C	0	.	.	133	135	CGC	295	297	CGC	21;21;21	C;G;C	21;21;21	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	220	acrS	663	663	98.79	acrS.l15.c4.ctg.1	924	12.4	0	.	p	.	0	L34F	NONSYN	100	102	CTC	173	175	TTC	12;11;9	T;T;C	12;11;9	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	220	acrS	663	663	98.79	acrS.l15.c4.ctg.1	924	12.4	0	.	p	.	0	E122G	NONSYN	364	366	GAG	437	439	GGG	12;11;11	G;G;G	12;11;11	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	264	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1164	12.1	0	.	p	.	0	V136L	NONSYN	406	408	GTT	601	603	CTT	14;15;17	C;T;T	14;15;17	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	816	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3029	14.4	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2030	2032	GCA	13;13;11	G;C;A	13;13;11	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	816	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3029	14.4	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2291	2293	ACC	24;24;24	A;C;C	24;24;24	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	816	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3029	14.4	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2600	2602	GCC	18;16;15	G;C;C	18;15;15	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	404	arnA_1	1983	1556	98.71	arnA_1.l15.c4.ctg.1	1736	10.6	0	.	p	.	0	I150V	NONSYN	448	450	ATT	21	23	GTT	7;7;7	G;T;T	7;7;7	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	404	arnA_1	1983	1556	98.71	arnA_1.l15.c4.ctg.1	1736	10.6	0	.	p	.	0	R200H	NONSYN	598	600	CGC	171	173	CAC	10;10;10	C;A;C	10;10;10	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	404	arnA_1	1983	1556	98.71	arnA_1.l15.c4.ctg.1	1736	10.6	0	.	p	.	0	T295M	NONSYN	883	885	ACG	456	458	ATG	17;17;17	A;T;G	16;16;16	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	404	arnA_1	1983	1556	98.71	arnA_1.l15.c4.ctg.1	1736	10.6	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1452	1454	CGC	5;5;4	C;G;C	5;5;4	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	404	arnA_1	1983	205	96.1	arnA_1.l15.c4.ctg.2	206	5.5	0	.	p	.	0	D77E	NONSYN	229	231	GAT	5	7	GAG	1;1;2	G;A;G	1;1;2	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	404	arnA_1	1983	205	96.1	arnA_1.l15.c4.ctg.2	206	5.5	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	41	43	TGC	4;4;4	T;G;C	4;4;4	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	404	arnA_1	1983	126	96.83	arnA_1.l15.c4.ctg.3	128	8.9	0	.	p	.	0	G37A	NONSYN	109	111	GGT	5	7	GCT	2;4;4	G;C;T	2;4;4	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	220	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1042	10.6	0	.	p	.	0	S221T	NONSYN	661	663	AGC	849	851	ACC	9;10;11	A;C;C	9;10;11	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	220	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1042	10.6	0	.	p	.	0	P225S	NONSYN	673	675	CCG	861	863	TCG	7;8;8	T;C;G	7;8;8	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	19	170	baeR	723	687	97.67	baeR.l15.c4.ctg.1	856	9.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	262	baeS	1404	1258	98.89	baeS.l6.c4.ctg.1	1457	8.6	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1325	1327	AAA	5;6;6	A;A;A	5;6;5	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	262	baeS	1404	1258	98.89	baeS.l6.c4.ctg.1	1457	8.6	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1337	1339	GAG	7;8;7	G;A;G	6;8;7	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	262	baeS	1404	1258	98.89	baeS.l6.c4.ctg.1	1457	8.6	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1343	1345	CAC	6;6;6	C;A;C	5;5;6	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	262	baeS	1404	1258	98.89	baeS.l6.c4.ctg.1	1457	8.6	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1397	1399	GAG	5;5;5	G;A;G	5;5;5	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	262	baeS	1404	147	98.64	baeS.l6.c4.ctg.2	159	6.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	444	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1678	14.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	286	cpxR	699	699	99.43	cpxR.l15.c17.ctg.1	1104	13.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	230	cysB	975	975	99.38	cysB.l6.c4.ctg.1	1251	9.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	276	emrA	1173	1173	98.21	emrA.l15.c4.ctg.1	1207	11.4	0	.	p	.	0	W42C	NONSYN	124	126	TGG	139	141	TGT	6;6;5	T;G;T	6;6;5	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	276	emrA	1173	1173	98.21	emrA.l15.c4.ctg.1	1207	11.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	670	672	GTC	9;9;9	G;T;C	9;9;9	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	276	emrA	1173	1173	98.21	emrA.l15.c4.ctg.1	1207	11.4	0	.	p	.	0	G234A	NONSYN	700	702	GGG	715	717	GCG	8;9;9	G;C;G	8;9;9	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	480	emrB	1539	1539	99.81	emrB.l6.c30.ctg.1	1877	13.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	330	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1375	12.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	796	798	AGC	10;10;9	A;G;C	10;10;9	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	16	emrE_1	333	79	96.2	emrE_1.l15.c4.ctg.1	79	5.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	513	320	emrK	1056	477	98.32	emrK.l15.c4.ctg.1	679	11.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	513	320	emrK	1056	553	98.19	emrK.l15.c4.ctg.2	573	13.5	0	.	p	.	0	K176R	NONSYN	526	528	AAG	23	25	AGG	5;5;5	A;G;G	5;5;5	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	513	320	emrK	1056	553	98.19	emrK.l15.c4.ctg.2	573	13.5	0	.	p	.	0	N306D	NONSYN	916	918	AAC	413	415	GAC	10;9;9	G;A;C	10;9;9	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	196	emrR	531	531	100.0	emrR.l15.c4.ctg.1	913	11.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	464	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1926	12.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	192	evgA	615	615	99.19	evgA.l15.c4.ctg.1	891	11.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	265	267	CTG	15;15;16	C;T;G	15;15;16	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	963	96.78	evgS.l6.c30.ctg.1	963	9.1	0	.	p	.	0	A93T	NONSYN	277	279	GCG	153	155	ACG	9;9;9	A;C;G	9;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	963	96.78	evgS.l6.c30.ctg.1	963	9.1	0	.	p	.	0	A114E	NONSYN	340	342	GCA	216	218	GAA	10;10;10	G;A;A	10;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	963	96.78	evgS.l6.c30.ctg.1	963	9.1	0	.	p	.	0	T127A	NONSYN	379	381	ACT	255	257	GCT	10;9;9	G;C;T	9;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	963	96.78	evgS.l6.c30.ctg.1	963	9.1	0	.	p	.	0	N133D	NONSYN	397	399	AAT	273	275	GAT	8;8;8	G;A;T	8;8;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	963	96.78	evgS.l6.c30.ctg.1	963	9.1	0	.	p	.	0	P162S	NONSYN	484	486	CCA	360	362	TCA	5;5;5	T;C;A	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	963	96.78	evgS.l6.c30.ctg.1	963	9.1	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	489	491	CAG	8;9;9	C;A;G	8;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	963	96.78	evgS.l6.c30.ctg.1	963	9.1	0	.	p	.	0	I251V	NONSYN	751	753	ATT	627	629	GTT	13;13;11	G;T;T	13;13;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	963	96.78	evgS.l6.c30.ctg.1	963	9.1	0	.	p	.	0	N303D	NONSYN	907	909	AAT	783	785	GAT	6;6;6	G;A;T	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	963	96.78	evgS.l6.c30.ctg.1	963	9.1	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	951	953	AAT	3;3;3	A;A;T	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	2503	97.8	evgS.l6.c30.ctg.2	2675	13.9	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	5	7	TTA	1;1;1	T;T;A	1;1;1	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	2503	97.8	evgS.l6.c30.ctg.2	2675	13.9	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	206	208	AAA	8;8;8	A;A;A	8;8;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	2503	97.8	evgS.l6.c30.ctg.2	2675	13.9	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	941	943	CAT	8;9;9	C;A;T	8;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	2503	97.8	evgS.l6.c30.ctg.2	2675	13.9	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	995	997	CAT	10;9;9	C;A;T	10;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	2503	97.8	evgS.l6.c30.ctg.2	2675	13.9	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1013	1015	AGA	10;9;9	A;G;A	10;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	2503	97.8	evgS.l6.c30.ctg.2	2675	13.9	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1028	1030	AAT	12;12;12	A;A;T	12;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	2503	97.8	evgS.l6.c30.ctg.2	2675	13.9	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1175	1177	TCC	6;6;7	T;C;C	6;6;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	2503	97.8	evgS.l6.c30.ctg.2	2675	13.9	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1340	1342	ATT	9;8;7	A;T;T	9;8;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	2503	97.8	evgS.l6.c30.ctg.2	2675	13.9	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1361	1363	GAT	13;14;14	G;A;T	13;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	2503	97.8	evgS.l6.c30.ctg.2	2675	13.9	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1475	1477	GTT	16;16;16	G;T;T	16;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	2503	97.8	evgS.l6.c30.ctg.2	2675	13.9	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1760	1762	CAC	12;12;12	C;A;C	12;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	2503	97.8	evgS.l6.c30.ctg.2	2675	13.9	0	.	p	.	0	D1197N	NONSYN	3589	3591	GAC	2498	2500	AAC	7;7;7	A;A;C	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	900	evgS	3594	112	100.0	evgS.l6.c30.ctg.3	168	10.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	272	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1059	13.3	1	SNP	p	P64A	0	.	.	190	192	CCA	307	309	CCA	19;18;19	C;C;A	18;18;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	272	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1059	13.3	1	SNP	p	P64H	0	.	.	190	192	CCA	307	309	CCA	19;18;19	C;C;A	18;18;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	272	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1059	13.3	1	SNP	p	P64R	0	.	.	190	192	CCA	307	309	CCA	19;18;19	C;C;A	18;18;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	272	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1059	13.3	1	SNP	p	P64S	0	.	.	190	192	CCA	307	309	CCA	19;18;19	C;C;A	18;18;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	272	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1059	13.3	1	SNP	p	P64L	0	.	.	190	192	CCA	307	309	CCA	19;18;19	C;C;A	18;18;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	226	gadE	528	528	100.0	gadE.l15.c30.ctg.1	942	12.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	16	48	gadW	729	120	97.5	gadW.l15.c4.ctg.1	120	8.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	246	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1028	12.6	0	.	p	.	0	F53L	NONSYN	157	159	TTC	285	287	TTA	16;16;17	T;T;A	16;16;17	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	246	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1028	12.6	0	.	p	.	0	V79I	NONSYN	235	237	GTT	363	365	ATT	13;13;13	A;T;T	13;13;13	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	246	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1028	12.6	0	.	p	.	0	R246G	NONSYN	736	738	AGA	864	866	GGA	6;7;7	G;G;A	6;7;7	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	246	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1028	12.6	0	.	p	.	0	S248P	NONSYN	742	744	TCG	870	872	CCG	6;6;6	C;C;G	6;6;6	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	702	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2915	12.7	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2108	2110	GAA	6;6;6	G;A;A	6;6;6	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	702	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2915	12.7	1	SNP	p	S83I	0	.	.	247	249	TCG	323	325	TCG	17;17;17	T;C;G	17;17;17	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	702	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2915	12.7	1	SNP	p	S83L	0	.	.	247	249	TCG	323	325	TCG	17;17;17	T;C;G	17;17;17	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	702	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2915	12.7	1	SNP	p	S83W	0	.	.	247	249	TCG	323	325	TCG	17;17;17	T;C;G	17;17;17	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	702	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2915	12.7	1	SNP	p	D87N	0	.	.	259	261	GAC	335	337	GAC	16;17;19	G;A;C	14;16;17	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	702	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2915	12.7	1	SNP	p	D87V	0	.	.	259	261	GAC	335	337	GAC	16;17;19	G;A;C	14;16;17	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	702	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2915	12.7	1	SNP	p	D87H	0	.	.	259	261	GAC	335	337	GAC	16;17;19	G;A;C	14;16;17	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	702	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2915	12.7	1	SNP	p	D87Y	0	.	.	259	261	GAC	335	337	GAC	16;17;19	G;A;C	14;16;17	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	702	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2915	12.7	1	SNP	p	D87G	0	.	.	259	261	GAC	335	337	GAC	16;17;19	G;A;C	14;16;17	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	786	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2771	15.2	1	SNP	p	R136L	0	.	.	406	408	CGC	600	602	CGC	20;21;21	C;G;C	20;21;21	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	786	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2771	15.2	1	SNP	p	R136S	0	.	.	406	408	CGC	600	602	CGC	20;21;21	C;G;C	20;21;21	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	786	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2771	15.2	1	SNP	p	R136E	0	.	.	406	408	CGC	600	602	CGC	20;21;21	C;G;C	20;21;21	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	786	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2771	15.2	1	SNP	p	R136C	0	.	.	406	408	CGC	600	602	CGC	20;21;21	C;G;C	20;21;21	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	786	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2771	15.2	1	SNP	p	R136H	0	.	.	406	408	CGC	600	602	CGC	20;21;21	C;G;C	20;21;21	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	786	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2771	15.2	1	SNP	p	R136I	0	.	.	406	408	CGC	600	602	CGC	20;21;21	C;G;C	20;21;21	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	786	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2771	15.2	1	SNP	p	R136G	0	.	.	406	408	CGC	600	602	CGC	20;21;21	C;G;C	20;21;21	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	152	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	890	8.7	0	.	p	.	0	A72P	NONSYN	214	216	GCG	298	300	CCG	12;12;10	C;C;G	11;11;10	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	152	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	890	8.7	0	.	p	.	0	T123A	NONSYN	367	369	ACC	451	453	GCC	10;11;11	G;C;C	10;11;11	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	370	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1196	16.3	0	.	p	.	0	P9S	NONSYN	25	27	CCA	81	83	TCA	11;11;11	T;C;A	11;11;11	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	106	marA	384	384	99.74	marA.l15.c30.ctg.1	636	8.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	66	marR	435	395	97.97	marR.l6.c30.ctg.1	599	5.8	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	508	510	AGC	2;2;2	A;G;C	2;2;2	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	66	marR	435	395	97.97	marR.l6.c30.ctg.1	599	5.8	1	SNP	p	V45E	0	.	.	133	135	GTG	334	336	GTG	8;8;8	G;T;G	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	66	marR	435	395	97.97	marR.l6.c30.ctg.1	599	5.8	1	SNP	p	I49S	0	.	.	145	147	ATC	346	348	ATC	7;7;7	A;T;C	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	66	marR	435	395	97.97	marR.l6.c30.ctg.1	599	5.8	1	SNP	p	A70T	0	.	.	208	210	GCA	409	411	GCA	8;8;7	G;C;A	8;8;7	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	66	marR	435	395	97.97	marR.l6.c30.ctg.1	599	5.8	1	SNP	p	R73S	0	.	.	217	219	CGT	418	420	CGT	8;8;8	C;G;T	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	66	marR	435	395	97.97	marR.l6.c30.ctg.1	599	5.8	1	SNP	p	R73C	0	.	.	217	219	CGT	418	420	CGT	8;8;8	C;G;T	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	66	marR	435	395	97.97	marR.l6.c30.ctg.1	599	5.8	1	SNP	p	R77L	0	.	.	229	231	CGC	430	432	CGC	7;7;7	C;G;C	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	66	marR	435	395	97.97	marR.l6.c30.ctg.1	599	5.8	1	SNP	p	R77C	0	.	.	229	231	CGC	430	432	CGC	7;7;7	C;G;C	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	66	marR	435	395	97.97	marR.l6.c30.ctg.1	599	5.8	1	SNP	p	L78M	0	.	.	232	234	CTG	433	435	CTG	7;7;6	C;T;G	7;7;6	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	66	marR	435	395	97.97	marR.l6.c30.ctg.1	599	5.8	1	SNP	p	R94H	0	.	.	280	282	CGC	481	483	CGC	2;2;2	C;G;C	2;2;2	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	66	marR	435	395	97.97	marR.l6.c30.ctg.1	599	5.8	1	SNP	p	R94S	0	.	.	280	282	CGC	481	483	CGC	2;2;2	C;G;C	2;2;2	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	66	marR	435	395	97.97	marR.l6.c30.ctg.1	599	5.8	1	SNP	p	V96E	0	.	.	286	288	GTA	487	489	GTA	1;1;1	G;T;A	1;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	196	mdfA	1233	144	95.14	mdfA.l6.c4.ctg.1	144	2.6	0	.	p	.	0	E52D	NONSYN	154	156	GAG	6	8	GAT	2;2;2	G;A;T	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	196	mdfA	1233	144	95.14	mdfA.l6.c4.ctg.1	144	2.6	0	.	p	.	0	N59T	NONSYN	175	177	AAC	27	29	ACC	2;2;2	A;C;C	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	196	mdfA	1233	144	95.14	mdfA.l6.c4.ctg.1	144	2.6	0	.	p	.	0	I68L	NONSYN	202	204	ATA	54	56	TTA	2;1;1	T;T;A	2;1;1	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	196	mdfA	1233	886	97.74	mdfA.l6.c4.ctg.2	881	10.0	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	42	44	CAG	9;9;9	C;A;G	9;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	196	mdfA	1233	886	97.74	mdfA.l6.c4.ctg.2	881	10.0	0	.	p	.	0	D128A	NONSYN	382	384	GAC	81	83	GCC	3;3;3	G;C;C	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	196	mdfA	1233	886	97.74	mdfA.l6.c4.ctg.2	881	10.0	0	.	p	.	0	S163A	NONSYN	487	489	TCG	186	188	GCG	7;8;8	G;C;G	7;8;8	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	196	mdfA	1233	886	97.74	mdfA.l6.c4.ctg.2	881	10.0	0	.	p	.	0	L231V	NONSYN	691	693	CTT	390	392	GTT	7;8;8	G;T;T	3;6;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	196	mdfA	1233	886	97.74	mdfA.l6.c4.ctg.2	881	10.0	0	.	p	.	0	R285fs	FSHIFT	853	853	C	552	552	C	8	C	8	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	214	mdtA	1248	767	98.17	mdtA.l6.c30.ctg.1	852	9.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	214	mdtA	1248	226	96.02	mdtA.l6.c30.ctg.2	220	6.7	0	.	p	.	0	V12trunc	TRUNC	34	34	G	30	30	G	12	G	12	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	214	mdtA	1248	226	96.02	mdtA.l6.c30.ctg.2	220	6.7	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	87	89	CAG	2;3;2	C;A;G	2;3;2	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	754	mdtB	3123	3098	99.0	mdtB.l15.c30.ctg.1	3297	12.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1946	1948	ACC	12;12;12	A;C;C	12;12;12	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	754	mdtB	3123	3098	99.0	mdtB.l15.c30.ctg.1	3297	12.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2339	2341	CAA	7;7;6	C;A;A	7;7;6	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	754	mdtB	3123	3098	99.0	mdtB.l15.c30.ctg.1	3297	12.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2507	2509	ATT	6;5;5	A;T;T	6;5;5	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	754	mdtB	3123	3098	99.0	mdtB.l15.c30.ctg.1	3297	12.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2591	2593	GTT	14;14;13	G;T;T	14;14;13	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	754	mdtB	3123	3098	99.0	mdtB.l15.c30.ctg.1	3297	12.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2699	2701	GAG	4;4;5	G;A;G	4;4;5	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	754	mdtB	3123	3098	99.0	mdtB.l15.c30.ctg.1	3297	12.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2927	2929	ATG	5;5;5	A;T;G	5;5;5	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	754	mdtB	3123	3098	99.0	mdtB.l15.c30.ctg.1	3297	12.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3062	3064	GAT	9;9;9	G;A;T	9;6;9	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	640	mdtC	3078	2875	98.78	mdtC.l6.c4.ctg.1	2931	11.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	135	137	ATG	3;3;3	A;T;G	3;3;3	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	640	mdtC	3078	2875	98.78	mdtC.l6.c4.ctg.1	2931	11.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	621	623	ATC	15;15;15	A;T;C	15;15;15	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	640	mdtC	3078	101	98.02	mdtC.l6.c4.ctg.3	198	4.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	268	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1733	8.2	0	.	p	.	0	D3E	NONSYN	7	9	GAT	138	140	GAA	7;7;7	G;A;A	7;7;7	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	268	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1733	8.2	0	.	p	.	0	T226A	NONSYN	676	678	ACG	807	809	GCG	9;9;9	G;C;G	9;9;9	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	268	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1733	8.2	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1149	1151	ATC	8;8;8	A;T;C	8;8;8	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	268	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1733	8.2	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1452	1454	TTT	9;10;11	T;T;T	9;10;11	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	398	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1530	13.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	920	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3540	13.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1075	1077	ACC	16;16;16	A;C;C	16;16;16	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	920	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3540	13.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2317	2319	GAC	16;17;18	G;A;C	16;17;18	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	316	mdtG	1227	1047	99.43	mdtG.l6.c4.ctg.1	1453	8.7	0	.	p	.	0	V200I	NONSYN	598	600	GTC	584	586	ATC	13;12;12	A;T;C	13;12;12	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	316	mdtG	1227	182	99.45	mdtG.l6.c4.ctg.2	328	9.5	0	.	p	.	0	E5G	NONSYN	13	15	GAA	150	152	GGA	3;3;4	G;G;A	3;3;4	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	232	mdtH	1209	1065	98.4	mdtH.l6.c4.ctg.1	1261	8.6	0	.	p	.	0	G134C	NONSYN	400	402	GGT	550	552	TGT	14;13;13	T;G;T	14;13;13	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	232	mdtH	1209	1065	98.4	mdtH.l6.c4.ctg.1	1261	8.6	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1120	1122	TTG	7;7;7	T;T;G	7;7;7	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	232	mdtH	1209	150	96.67	mdtH.l6.c4.ctg.3	166	6.5	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	121	123	ACG	3;3;3	A;C;G	3;3;3	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	342	mdtL	1176	1176	98.21	mdtL.l15.c30.ctg.1	1341	13.3	0	.	p	.	0	A185S	NONSYN	553	555	GCC	665	667	TCC	6;9;9	T;C;C	6;9;9	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	274	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1396	10.5	0	.	p	.	0	V119I	NONSYN	355	357	GTT	538	540	ATT	11;10;10	A;T;T	11;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	524	mdtO	2052	2052	98.05	mdtO.l6.c4.ctg.1	2258	12.3	0	.	p	.	0	V11M	NONSYN	31	33	GTG	35	37	ATG	11;11;11	A;T;G	10;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	524	mdtO	2052	2052	98.05	mdtO.l6.c4.ctg.1	2258	12.3	0	.	p	.	0	T33I	NONSYN	97	99	ACC	101	103	ATC	7;7;7	A;T;C	7;7;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	524	mdtO	2052	2052	98.05	mdtO.l6.c4.ctg.1	2258	12.3	0	.	p	.	0	C116R	NONSYN	346	348	TGC	350	352	CGC	19;19;18	C;G;C	19;19;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	524	mdtO	2052	2052	98.05	mdtO.l6.c4.ctg.1	2258	12.3	0	.	p	.	0	N238S	NONSYN	712	714	AAC	716	718	AGC	13;13;13	A;G;C	13;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	524	mdtO	2052	2052	98.05	mdtO.l6.c4.ctg.1	2258	12.3	0	.	p	.	0	M305V	NONSYN	913	915	ATG	917	919	GTG	6;6;6	G;T;G	6;6;6	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	524	mdtO	2052	2052	98.05	mdtO.l6.c4.ctg.1	2258	12.3	0	.	p	.	0	D326N	NONSYN	976	978	GAC	980	982	AAC	5;5;5	A;A;C	4;4;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	524	mdtO	2052	2052	98.05	mdtO.l6.c4.ctg.1	2258	12.3	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1025	1027	GTC	9;9;9	G;T;C	9;7;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	524	mdtO	2052	2052	98.05	mdtO.l6.c4.ctg.1	2258	12.3	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1055	1057	ATA	15;15;15	A;T;A	15;15;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	524	mdtO	2052	2052	98.05	mdtO.l6.c4.ctg.1	2258	12.3	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1163	1165	TCT	9;9;9	T;C;T	9;9;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	524	mdtO	2052	2052	98.05	mdtO.l6.c4.ctg.1	2258	12.3	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1550	1552	GCG	13;13;13	G;C;G	13;13;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	524	mdtO	2052	2052	98.05	mdtO.l6.c4.ctg.1	2258	12.3	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1763	1765	ATC	19;18;17	A;T;C	19;18;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	352	mdtP	1467	1455	97.87	mdtP.l6.c4.ctg.1	1549	11.6	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	296	296	T	18	T	18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	352	mdtP	1467	1455	97.87	mdtP.l6.c4.ctg.1	1549	11.6	0	.	p	.	0	S129A	NONSYN	385	387	TCA	479	481	GCG	6;6;7	G;C;G	6;6;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	352	mdtP	1467	1455	97.87	mdtP.l6.c4.ctg.1	1549	11.6	0	.	p	.	0	A187T	NONSYN	559	561	GCC	653	655	ACC	13;12;12	A;C;C	13;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	352	mdtP	1467	1455	97.87	mdtP.l6.c4.ctg.1	1549	11.6	0	.	p	.	0	H211R	NONSYN	631	633	CAC	725	727	CGC	11;10;10	C;G;C	11;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	352	mdtP	1467	1455	97.87	mdtP.l6.c4.ctg.1	1549	11.6	0	.	p	.	0	V250A	NONSYN	748	750	GTT	842	844	GCT	8;8;8	G;C;T	8;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	352	mdtP	1467	1455	97.87	mdtP.l6.c4.ctg.1	1549	11.6	0	.	p	.	0	R278K	NONSYN	832	834	AGA	926	928	AAA	4;4;4	A;A;A	4;4;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	352	mdtP	1467	1455	97.87	mdtP.l6.c4.ctg.1	1549	11.6	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	944	946	CGA	3;4;4	C;G;A	3;4;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	352	mdtP	1467	1455	97.87	mdtP.l6.c4.ctg.1	1549	11.6	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1109	1111	GCC	5;5;5	G;C;C	5;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	352	mdtP	1467	1455	97.87	mdtP.l6.c4.ctg.1	1549	11.6	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1121	1123	GAT	6;6;5	G;A;T	6;6;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	352	mdtP	1467	1455	97.87	mdtP.l6.c4.ctg.1	1549	11.6	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1538	1540	GCT	3;3;3	G;C;T	3;3;3	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	800	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3463	11.8	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1311	1313	AAG	11;11;11	A;A;G	11;11;11	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	800	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3463	11.8	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2388	2390	CTG	10;11;12	C;T;G	10;11;12	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	46	mgrB	144	144	100.0	mgrB.l15.c30.ctg.2	157	7.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	502	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	2019	13.3	0	.	p	.	0	S278N	NONSYN	832	834	AGC	924	926	AAC	13;13;13	A;A;C	13;13;13	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	502	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	2019	13.3	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1470	1472	ATA	16;18;19	A;T;A	16;18;19	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	406	murA_12	1260	1260	98.57	murA_12.l15.c17.ctg.1	1547	14.0	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1270	1272	GAT	17;17;17	G;A;T	17;17;17	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	406	murA_12	1260	1260	98.57	murA_12.l15.c17.ctg.1	1547	14.0	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1273	1275	CTG	17;16;15	C;T;G	17;16;15	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	182	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	862	10.2	0	.	p	.	0	R27C	NONSYN	79	81	CGT	93	95	TGT	18;18;18	T;G;T	18;18;18	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	182	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	862	10.2	0	.	p	.	0	I117T	NONSYN	349	351	ATC	363	365	ACC	5;5;5	A;C;C	5;5;5	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	182	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	862	10.2	0	.	p	.	0	G187D	NONSYN	559	561	GGC	573	575	GAC	8;8;8	G;A;C	8;8;8	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	182	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	862	10.2	1	SNP	p	R15C	0	.	.	43	45	CGC	57	59	CGC	19;19;19	C;G;C	19;19;19	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	182	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	862	10.2	1	SNP	p	S33R	0	.	.	97	99	AGC	111	113	AGC	12;12;12	A;G;C	12;12;12	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	182	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	862	10.2	1	SNP	p	G131D	0	.	.	391	393	GGC	405	407	GGC	8;8;7	G;G;C	8;8;6	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	182	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	862	10.2	1	SNP	p	R203L	0	.	.	607	609	CGT	621	623	CGT	7;8;9	C;G;T	7;8;9	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	182	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	862	10.2	1	SNP	p	R203C	0	.	.	607	609	CGT	621	623	CGT	7;8;9	C;G;T	7;8;9	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	430	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1440	15.8	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1086	1088	GAG	22;23;23	G;A;G	22;23;23	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	430	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1440	15.8	1	SNP	p	G141D	0	.	.	421	423	GGT	573	575	GGT	24;24;24	G;G;T	24;23;23	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	430	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1440	15.8	1	SNP	p	G141E	0	.	.	421	423	GGT	573	575	GGT	24;24;24	G;G;T	24;23;23	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	430	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1440	15.8	1	SNP	p	R154D	0	.	.	460	462	CGT	612	614	CGT	16;16;15	C;G;T	16;16;14	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	430	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1440	15.8	1	SNP	p	R154A	0	.	.	460	462	CGT	612	614	CGT	16;16;15	C;G;T	16;16;14	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	706	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2628	14.3	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1828	1830	TCG	19;20;19	T;C;G	19;19;18	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	706	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2628	14.3	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2443	2445	AAC	5;6;6	A;A;C	5;6;6	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	706	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2628	14.3	1	SNP	p	A85T	0	.	.	253	255	GCG	457	459	GCG	13;14;15	G;C;G	13;13;14	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	706	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2628	14.3	1	SNP	p	D111H	0	.	.	331	333	GAT	535	537	GAT	11;10;11	G;A;T	11;10;11	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	706	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2628	14.3	1	SNP	p	S129P	0	.	.	385	387	TCC	589	591	TCC	10;10;9	T,C;C;C	9,1;10;9	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	1	492	parE_1	1893	947	96.73	parE_1.l6.c4.ctg.1	947	11.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	1	492	parE_1	1893	166	98.8	parE_1.l6.c4.ctg.2	405	8.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	1	492	parE_1	1893	753	98.54	parE_1.l6.c4.ctg.3	929	13.3	1	SNP	p	D476N	0	.	.	1426	1428	GAT	286	288	GAT	18;18;17	G;A;T	18;18;17	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	392	patA	1380	1380	99.86	patA.l15.c4.ctg.1	1798	11.6	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1268	1270	GAT	8;8;8	G;A;T	8;8;8	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1394	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4267	17.3	1	SNP	p	V146F	0	.	.	436	438	GTT	577	579	GTT	14;13;12	G;T;T	14;13;12	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1394	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4267	17.3	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1678	1680	CAG	19;19;18	C;A;G	19;19;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1394	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4267	17.3	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1678	1680	CAG	19;19;18	C;A;G	19;19;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1394	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4267	17.3	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1717	1719	CAC	14;15;15	C;A;C	14;15;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1394	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4267	17.3	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1726	1728	CGT	14;14;15	C;G;T	14;14;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1394	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4267	17.3	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1726	1728	CGT	14;14;15	C;G;T	14;14;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1394	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4267	17.3	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1732	1734	TCC	17;18;18	T;C;C	16;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1394	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4267	17.3	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1738	1740	CTC	16;16;16	C;T;C	16;15;16	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1394	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4267	17.3	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1828	1830	ACC	14;14;15	A;C;C	14;14;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1394	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4267	17.3	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1831	1833	CCT	14;14;14	C;C;T	14;14;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1394	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4267	17.3	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2200	2202	CGT	21;19;19	C;G;T	21;19;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	0	.	n	.	0	A226G	SNP	226	226	A	374	374	G	109	G	109	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	1	SNP	n	A794T	0	.	.	794	794	A	942	942	A	120	A	120	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	1	SNP	n	A794G	0	.	.	794	794	A	942	942	A	120	A	120	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	1	SNP	n	G926A	0	.	.	926	926	G	1074	1074	G	108	G	108	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	1	SNP	n	G926T	0	.	.	926	926	G	1074	1074	G	108	G	108	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	1	SNP	n	G926C	0	.	.	926	926	G	1074	1074	G	108	G	108	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	0	HET	.	.	.	A79G	.	79	79	A	227	227	A	91	A,G	65,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	0	HET	.	.	.	C719T	.	719	719	C	867	867	C	95	C,T	54,40	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	0	HET	.	.	.	T273A	.	273	273	T	421	421	T	93	T,A	69,21	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	0	HET	.	.	.	C183T	.	183	183	C	331	331	C	130	C,T	84,45	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	0	HET	.	.	.	T90C	.	90	90	T	238	238	T	92	T,C	66,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	0	HET	.	.	.	A250T	.	250	250	A	398	398	A	98	A,T	65,33	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	0	HET	.	.	.	G474A	.	474	474	G	622	622	G	112	G,A	90,22	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	0	HET	.	.	.	A253T	.	253	253	A	401	401	A	102	A,T	68,33	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1149	102.6	0	HET	.	.	.	C194T	.	194	194	C	342	342	C	123	C,T	101,22	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	517	118.0	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	65	A,C	64,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	517	118.0	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	65	A,C	64,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	517	118.0	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	65	A,C	64,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	141	100.0	rrsB+.l15.c30.ctg.3	141	23.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	136	94.89	rrsB+.l15.c30.ctg.6	136	19.4	0	.	n	.	0	G1002A	SNP	1002	1002	G	50	50	A	28	A	28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	136	94.89	rrsB+.l15.c30.ctg.6	136	19.4	0	.	n	.	0	G1006C	SNP	1006	1006	G	54	54	C	31	C	31	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	136	94.89	rrsB+.l15.c30.ctg.6	136	19.4	0	.	n	.	0	T1010C	SNP	1010	1010	T	58	58	C	28	C	28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	136	94.89	rrsB+.l15.c30.ctg.6	136	19.4	0	.	n	.	0	A1019.	DEL	1019	1019	A	66	66	G	32	G	32	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	136	94.89	rrsB+.l15.c30.ctg.6	136	19.4	0	.	n	.	0	.1023G	INS	1023	1023	T	71	71	G	32	G	32	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	3772	rrsB+	1542	136	94.89	rrsB+.l15.c30.ctg.6	136	19.4	0	.	n	.	0	C1038T	SNP	1038	1038	C	86	86	T	33	T	33	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	186	soxR	465	465	100.0	soxR.l6.c4.ctg.1	742	12.9	1	SNP	p	R20H	0	.	.	58	60	CGC	214	216	CGC	11;11;11	C;G;C	11;11;11	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	186	soxR	465	465	100.0	soxR.l6.c4.ctg.1	742	12.9	1	SNP	p	G121D	0	.	.	361	363	GGT	517	519	GGT	15;13;13	G;G;T	15;13;13	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	120	soxS_1	324	324	99.69	soxS_1.l15.c17.ctg.1	691	9.1	1	SNP	p	A12S	0	.	.	34	36	GCA	213	215	GCA	14;14;13	G;C;A	14;14;12	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	548	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1872	15.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
